SCHEMBL13436397

SCHEMBL13436397

COc1ccc2c(c1)C(=O)N(C[C@]1(c3ccc(-c4cnccn4)cc3)NC(=O)NC1=O)C2

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ADAM17 P78536 20/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8228076 1.00 ADAM17 (1.00) ADAM17
SCHEMBL8232178 0.93 ADAM17 (0.88) ADAM17
SCHEMBL8227908 0.93 ADAM17 (0.86) ADAM17
SCHEMBL8420462 0.90 ADAM17 (0.82) ADAM17
SCHEMBL13773440 0.90 ADAM17 (0.82) ADAM17
SCHEMBL14466437 0.89 ADAM17 (0.81) ADAM17
SCHEMBL6005070 0.89 ADAM17 (1.00) ADAM17
SCHEMBL8227390 0.89 ADAM17 (0.81) ADAM17
SCHEMBL8226936 0.89 ADAM17 (0.80) ADAM17
SCHEMBL8226960 0.89 ADAM17 (0.80) ADAM17

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7687527-B2 Compounds for the treatment of inflammatory disorders SCHERING CORPORATION (US) 2010-03-30 US disclosed